Results 241 to 250 of about 51,607 (296)

FHL1 as a prognostic biomarker and therapeutic target in acute promyelocytic leukaemia. [PDF]

open access: yesDiscov Oncol
Luo B   +7 more
europepmc   +1 more source

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy. [PDF]

open access: yesBlood Adv
Uy GL   +11 more
europepmc   +1 more source

Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia. [PDF]

open access: yesBlood Adv
Brown FC   +14 more
europepmc   +1 more source

How to improve AML outcomes? [PDF]

open access: yesBlood Res
Tan T, Bozdag SC.
europepmc   +1 more source

Clinical analysis of ten cases of HIV infection combined with acute leukemia. [PDF]

open access: yesOpen Med (Wars)
Fan S   +7 more
europepmc   +1 more source

Therapeutics of acute myeloid leukemia with central nervous system involvement. [PDF]

open access: yesClin Hematol Int
Suárez EU   +5 more
europepmc   +1 more source

Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries. [PDF]

open access: yesAm J Hematol
Récher C   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy